Veracyte, Inc.VCYTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank51
3Y CAGR-23.3%
5Y CAGR-9.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-23.3%/yr
vs +1.7%/yr prior
5Y CAGR
-9.7%/yr
Recent deceleration
Acceleration
-25.0pp
Decelerating
Percentile
P51
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.49% |
| Q3 2025 | 33.19% |
| Q2 2025 | 526.73% |
| Q1 2025 | -78.14% |
| Q4 2024 | -18.15% |
| Q3 2024 | 1.31% |
| Q2 2024 | 429.86% |
| Q1 2024 | -157.65% |
| Q4 2023 | 9.75% |
| Q3 2023 | -15.00% |
| Q2 2023 | 867.54% |
| Q1 2023 | -122.29% |
| Q4 2022 | 38.68% |
| Q3 2022 | 2035.54% |
| Q2 2022 | 95.91% |
| Q1 2022 | -205.04% |
| Q4 2021 | 706.32% |
| Q3 2021 | -173.82% |
| Q2 2021 | 104.65% |
| Q1 2021 | -1893.94% |
| Q4 2020 | 29.05% |
| Q3 2020 | 120.80% |
| Q2 2020 | -58.89% |
| Q1 2020 | -396.15% |
| Q4 2019 | 215.04% |
| Q3 2019 | 36.62% |
| Q2 2019 | -142.83% |
| Q1 2019 | 17.54% |
| Q4 2018 | 31.24% |
| Q3 2018 | 42.47% |
| Q2 2018 | 58.20% |
| Q1 2018 | -27.46% |
| Q4 2017 | -13.97% |
| Q3 2017 | -3.93% |
| Q2 2017 | 39.28% |
| Q1 2017 | -91.07% |
| Q4 2016 | 43.10% |
| Q3 2016 | 3.58% |
| Q2 2016 | 10.28% |
| Q1 2016 | -203.82% |